🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested
This study will evaluate the efficacy and safety of mosunetuzumab in combin...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-10-27
Trial ID
NCT04712097
Treatments Being Tested
The purpose of this prospective, multicenter, Phase 2 study is to evaluate ...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences
Start Date
2026-04-10
Trial ID
NCT07555470
Treatments Being Tested
This study will evaluate the safety, tolerability, pharmacokinetics, pharma...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham School of Medicine
Start Date
2018-09-25
Trial ID
NCT03671018
Treatments Being Tested
This study is designed to evaluate the safety and efficacy of glofitamab or...
Status
Completed
Location
Prince of Wales Hospital; Haematology
Start Date
2020-06-04
Trial ID
NCT04313608
Treatments Being Tested
This study will assess the safety, tolerability, pharmaokinetics, and preli...
Status
Recruiting
Location
Mayo Clinic Rochester
Start Date
2022-03-07
Trial ID
NCT05091424
Treatments Being Tested
This study will evaluate the safety, efficacy, pharmacokinetics, and immuno...
Status
Active Not Recruiting
Location
City of Hope National Medical Center
Start Date
2020-08-12
Trial ID
NCT04246086
Treatments Being Tested
This study will evaluate the safety, efficacy, and pharmacokinetics of mosu...
Status
Terminated
Location
USC Norris Comprehensive Cancer Center
Start Date
2022-05-10
Trial ID
NCT05315713
Treatments Being Tested
This is a Phase 1/2 dose-escalation study of BTCT4465A (Mosunetuzumab) admi...
Status
Completed
Location
University of California San Diego Moores Cancer Center
Start Date
2015-09-15
Trial ID
NCT02500407
Treatments Being Tested
This single-arm, interventional phase 2 study is designed to evaluate wheth...
Status
Recruiting
Location
Froedtert Hospital & the Medical College of Wisconsin
Start Date
2026-06-01
Trial ID
NCT06594939
Treatments Being Tested